Study to Evaluate the Safety and Immunogenicity of a 10-valent Pneumococcal Conjugate Vaccine in Preterm Infants
Clinical trial NCT00390910 · COMPLETED
Trial details
- NCT number
- NCT00390910
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-10-01
- Primary completion
- 2007-07-02
- Enrollment
- 286
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.